摘要 |
<p>This disclosure describes novel 1-piperazinecarbonylcarboxamides and 1-piperazinethiocarboxamides, such as 4 min -chloro-4-(2-pyrazinyl)-1-piperazinecarboxanilide and 4 min -cyano-4(2-pyrazinyl)-1-piperazinethiocarboxanilide, pharmaeutical compositions containing same, a process for their preparation, and a method of treating atherosclerosis therewith.</p> |